Literature DB >> 8411028

Genetic risk: women's understanding of carrier risks in Duchenne muscular dystrophy.

E P Parsons1, A J Clarke.   

Abstract

This paper reports a study of 48 women (16 mothers and 32 daughters representing 28 families) who had lived with Duchenne muscular dystrophy (DMD) in their family. It looks at the way the women talked about their carrier risks during the course of an unstructured interview. It points to a significant difference between lay and health professionals' perspectives, in particular the thresholds they used to distinguish between high and low risk. A number of women, when quoting their risk in a mathematical form, confused their reproductive risks with their carrier risk, another indication of differential perceptions between the women and health professionals. There was evidence that several of the women did not retain their risk in a mathematical form but had translated it into a descriptive category which resolved their risk into greater certainty.

Entities:  

Mesh:

Year:  1993        PMID: 8411028      PMCID: PMC1016455          DOI: 10.1136/jmg.30.7.562

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  9 in total

1.  What do young people think about screening for cystic fibrosis?

Authors:  E Cobb; S Holloway; R Elton; J A Raeburn
Journal:  J Med Genet       Date:  1991-05       Impact factor: 6.318

2.  Carrier screening for cystic fibrosis.

Authors:  L P Ten Kate; T Tijmstra
Journal:  Lancet       Date:  1989-10-21       Impact factor: 79.321

3.  Identification of the cystic fibrosis gene: genetic analysis.

Authors:  B Kerem; J M Rommens; J A Buchanan; D Markiewicz; T K Cox; A Chakravarti; M Buchwald; L C Tsui
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

4.  Attitudes toward control and elimination of genetic defects.

Authors:  C R Margolin
Journal:  Soc Biol       Date:  1978

5.  Effect of fetal diagnostic testing on birth-rate of thalassaemia major in Britain.

Authors:  B Modell; M Petrou; R H Ward; D V Fairweather; C Rodeck; L A Varnavides; J M White
Journal:  Lancet       Date:  1984-12-15       Impact factor: 79.321

6.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

7.  Xamoterol in severe heart failure. The Xamoterol in Severe Heart Failure Study Group.

Authors: 
Journal:  Lancet       Date:  1990-07-07       Impact factor: 79.321

8.  Community attitudes to cystic fibrosis carrier testing in England: a pilot study.

Authors:  R Williamson; M E Allison; T J Bentley; S M Lim; E Watson; J Chapple; S Adam; M Boulton
Journal:  Prenat Diagn       Date:  1989-10       Impact factor: 3.050

9.  The cystic fibrosis gene: medical and social implications for heterozygote detection.

Authors:  B S Wilfond; N Fost
Journal:  JAMA       Date:  1990 May 23-30       Impact factor: 56.272

  9 in total
  3 in total

Review 1.  How risk is perceived, constructed and interpreted by clients in clinical genetics, and the effects on decision making: systematic review.

Authors:  Stephanie Sivell; Glyn Elwyn; Clara L Gaff; Angus J Clarke; Rachel Iredale; Chris Shaw; Joanna Dundon; Hazel Thornton; Adrian Edwards
Journal:  J Genet Couns       Date:  2007-10-30       Impact factor: 2.537

2.  Preconception counseling: do patients learn about genetics from their obstetrician gynecologists?

Authors:  Adrienne H Mandelberger; Jared C Robins; John E Buster; William C Strohsnitter; Beth J Plante
Journal:  J Assist Reprod Genet       Date:  2015-06-09       Impact factor: 3.412

3.  Attitudes towards bipolar disorder and predictive genetic testing among patients and providers.

Authors:  L B Smith; B Sapers; V I Reus; N B Freimer
Journal:  J Med Genet       Date:  1996-07       Impact factor: 6.318

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.